Bringing healing and hope through medical innovations
The U.S. Dependency on Foreign-Sourced Medical Products: A Growing Concern
The Big Problem: Ensuring Reliable Access to Life-Saving Medical Products
The U.S. relies heavily on foreign sources for critical medical supplies, posing a significant public health risk if supply chains are disrupted. Heparin, a widely used anticoagulant, is a prime example. More than 10 million Americans depend on it annually for treating blood clotting disorders, dialysis treatments for over 500,000 patients, and ECMO therapy for more than 10,000 individuals. Additionally, heparin and collagen-based products play a vital role in over 50 million surgeries each year, ensuring safer procedures and improved outcomes.
Read More
Chronic wound care is another area affected by this dependency. Over 6 million Americans suffer from chronic wounds, many requiring heparin or collagen-based treatments for healing. A supply disruption could lead to severe patient care issues and increased healthcare costs.
Reducing reliance on external sources is essential. Strengthening domestic production and securing supply chains are critical steps to ensure continued access to these life-saving medical products.